HMOX1 and glioblastoma: In this work, we extend the previous findings and show that HO‐1 inhibition abrogates immune suppression exerted by BMDMs separated from human GBM tissue specimens (Figure 2) and we demonstrate that, among the different HO‐1 inhibitors used, ZnPPIX is the most effective in modulating their activity.